Familial clustering of site-specific cancer risks associated with BRCA1 and BRCA2 mutations in the Ashkenazi Jewish population

Podobne zapisy

• Double heterozygotes for the Ashkenazi founder mutations in BRCA1 and BRCA2 genes.
  od: Friedman, E, i wsp.
  Wydane: (1998)
• Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families.
  od: Levy-Lahad, E, i wsp.
  Wydane: (1997)
• A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers
  od: Levy-Lahad, E., i wsp.
  Wydane: (2001)
• Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2
  od: Gabai-Kapara, Efrat, i wsp.
  Wydane: (2014)
• BRCA1 mutations in Ashkenazi Jewish women.
  od: Tonin, P, i wsp.
  Wydane: (1995)